Rayana AI
Account
TWST
HOLD / NEUTRALMeanRev
Composite
52.30
Technical
97.60
Fundamental
37.20
Rank
Price
151.42
Hurst
0.35
As of
Aug 26, 2026
Daily
Twist Bioscience Corporation
HealthcareBiotechnology

Twist Bioscience manufactures synthetic DNA and related molecular products used across therapeutics, diagnostics, materials science, agriculture, and academic research sectors. Its portfolio includes synthetic genes and oligonucleotide pools for applications like gene editing and sequencing, as well as diagnostic tools such as NGS kits and methylation detection assays for disease research. The company also produces viral reference controls and antibody engineering solutions for drug development, serving biotech, pharmaceutical, chemical, agricultural, and research institutions.

Market cap
$10.3B
P/E (trailing)
P/E (forward)
-245.94
PEG ratio
Dividend yield
Beta
2.22
52w range
23.30 – 163.70
Return on equity
-29.59%
Profit margin
-31.66%
Revenue growth
+23.20%
Earnings growth
Price history

1Y: 155.56 (+456.6%) · range 25.45–155.56

Cycle position
71/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 10 · NOT READY · exit proximity 70

Conviction
21/ 100 · maturity 100%
VScore.4023
Buildup.2017
EMA entry setup.2510
Fundamentals.1537
Volume profile
POC
58.41
Price vs POC
+166.3%
Overhead supply
1%
Runway
open sky

Value area 42.68103.19 · 1% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
squeeze-risk
0.475
Sep 17, 2026
short-interest
0.318
Sep 17, 2026
trend-signal
0.317
Sep 17, 2026
Forward returns
HorizonReturnMFEState
20d-15.22%+2.03%11/20d
40d-15.22%+2.03%11/40d